Overview

Evaluating the Effects of Tasimelteon vs Placebo on Sleep Disturbances in SMS

Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The aim of this study is to investigate tasimelteon vs. placebo on sleep disturbances of individuals with Smith-Magenis Syndrome.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Vanda Pharmaceuticals